V.V. BLINOVA¹, E.A. PANTELEEVA², A.A. MIRONOVA², E.S. BALABAEVA¹

¹Saratov State Medical University named after V.I. Razumovsky, Saratov

²Regional Clinical Cardiology Dispensary, Saratov

  Blinova V.V. ― PhD (medicine), Associate Professor of the Department of Therapy, Gastroenterology and Pulmonology

Address: 112 Bolshaya Kazachya Str., Saratov, Russian Federation, 410012, e-mail: blinowa.viky@yandex.ru

 Objective ― to present a brief literature review and a clinical case of a patient with pulmonary embolism due to thrombosis of a pacemaker electrode.

Material and methods. Literature and medical documentation of a patient with pulmonary embolism due to thrombosis of a pacemaker electrode (inpatient card) were studied.

Results. A brief review of medical literature on thromboembolic complications of cardiac pacing and clinical characteristics of the disease in the patient are given; laboratory and instrumental data are presented; the effectiveness of treatment with new oral anticoagulants is demonstrated.

Conclusion. For patients with implanted pacemakers, regardless of the timing of implantation, alertness to the development of complications, including thromboembolic ones, is necessary.

Key words: cardiac pacing, pulmonary artery thromboembolism, oral anticoagulants.

(For citation: Blinova V.V., Panteleeva E.A., Mironova A.A., Balabaeva E.S. Pulmonary embolism as a complication of permanent electrocardiostimulation: clinical case. Practical medicine. 2020. Vol. 18, №1, P.116-119)

 REFERENCES

1. Shal’nova S.A., Konradi A.O., Karpov Yu.A. et al. Analysis of mortality from cardiovascular diseases in 12 regions of the Russian Federation participating in the study “Epidemiology of cardiovascular diseases in various regions of Russia”. Rossiyskiy kardiologicheskiy zhurnal, 2012, no. 5, pp. 6-11 (in Russ.).
2. Chardack W.D., Gage A.A., Creatbatch W. Correction of complete heart bloc by a self-contained and subcutaneously implanted pacemaker: clinical experience with 15 patients. J. Thorac Cardiovasc Surg, 1961, vol. 42, p. 814.
3. Abdul’yanov I.V., Vagizov I.I. Modern approaches to constant pacing. Prakticheskaya meditsina, 2013, no. 3 (71), pp. 49-55 (in Russ.).
4. Bokeriya L.A., Revishvili A.Sh., Dubrovskiy I.A. Russian database on pacemaker: implantation, replacement and removal of electrodes in 2006. Vestnik aritmologii, 2008, no. 51, pp. 5-6 (in Russ.).
5. Posokhov I.N. Nemassivnaya tromboemboliya legochnoy arterii pri postoyannoy elekrokardiostimulyatsii v klinike vnutrennikh bolezney: dis. … d-ra med. nauk [Non-massive pulmonary thromboembolism with constant pacemaker in the clinic of internal diseases. Dis Dr med. sciences]. Tomsk, 2006. 253 p.
6. Van Rooden C.J., Tesselaar M.E., Osanto S. et al. Deep Venous thrombosis associated with central venous catheters ― a review. J. of Thrombosis and Haemostasis, 2005, vol. 3, p. 2409.
7. Hingorani A., Enrico A. Risk factors for mortality in patients with upper extremity and internal jugular deep venous thrombosis. J. of Vascular Surgery, 2005, vol. 41, pp. 476-478.
8. Qaseem A., Snow V., Barry P. et al. Current Diagnosis of Venous Thromboembolism in Primary Care: A Clinical Practice Guideline from the American of Family Physicians and the American College of Physicians. Pulmonary Embolism, 2007, vol. 146, pp. 454-458.
9. Rozmus G., Daubert J.P., Huang D.T. et al. Venous thrombosis and stenosis after implantation of pacemakers and defibrillators. J. Interv. Card. Electrophysion, 2005, vol. 13 (1), pp. 9-19.
10. Serdyukov D.A., Egorov D.F., Yudina O.V. Thromboembolic complications of constant pacing. Vestnik aritmologii, 2008, no. 54, pp. 48-54 (in Russ.).
11. Konstantinides S.V, Torbicki A., Agnelli G. et al. 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur. Heart J, 2014, vol. 35, pp. 3033-3069.
12. ESC recommendations for the diagnosis and management of patients with acute embolism of the pulmonary artery system 2014. Rossiyskiy kardiologicheskiy zhurnal, 2015, no. 8 (124), pp. 67-110 (in Russ.).
13. Bokeriya L.A., Gudkova R.G. Serdechno-sosudistaya khirurgiya ― 2011. Bolezni i vrozhdennye anomalii sistemy krovoobrashcheniya [Cardiovascular Surgery — 2011. Diseases and congenital malformations of the circulatory system]. Moscow: NTsSSKh im. A.N. Bakuleva RAMN, 2012. 196 p.
14. Shen J.H., Chen H.L., Chen J.R. Comparison of the Wells score with the revised Geneva score for assessing suspected pulmonary embolism: a systematic review and meta-analysis. J. Thromb. Thrombolys, 2016, vol. 41 (3), rr. 482-92.
15. Penaloza A., Melot C., Motte S. Comparison of the Wells score with the simplified revised Geneva score for assessing pretest probability of pulmonary embolism. Thromb. Res, 2015, vol. 127, pp. 81-4.
16. Bershteyn L.L. Pulmonary thromboembolism: clinical manifestations and diagnosis in the light of new recommendations of the European Society of Cardiology. Kardiologiya, 2015, no. 4, pp. 111-119 (in Russ.).
17. Tamayo S., Peacock F., Patel M. et al. Characterizing major bleeding in patients with non-valvular atrial fibrillation: a pharmacovlgllance study of 27,467 patients taking Rlvaroxaban. Clin. Cardiol, 2015, vol. 38 (2), pp. 63-8.
18. Van der Hulle T., Kooiman J., den Exter P.L. et al. Effectiveness and safety of novel oral anticoag-ulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis. J. Thromb. Haemost, 2014, vol. 12, pp. 320-328.
19. Buller H.R., Prins M.H., Lensin A.W. Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N. Engl. J. Med, 2012, vol. 366, pp. 1287-1297.
20. Petrov V.I., Shatalova O.V., Gorbatenko V.S. et al. Efficacy and safety of new oral anticoagulants in patients with venous thromboembolic complications: meta-analysis. Ratsional’naya farmakoterapiya v kardiologii, 2016, no. 1, pp. 31-39 (in Russ.).
21. Kakkos S.K., Kirkilesis S.I., Tsolakis I.A. Efficacy and safety of the new oral anticoagulants dabigatran, rivaroxaban, apixaban and edoxaban in the treatment and secondary prevention of venous thromboembolism: a systematic review and meta-analysis of phase III trials. Eur. J. Vasc. Endovasc. Surg, 2014, vol. 48, pp. 565-575.
22. Van Es J., Douma R.A., Kamphuisen P.W. et al. Clot resolution after 3 weeks of anticoagulant treatment for pulmonary embolism: comparison of computed tomography and perfusion scintigraphy. J. Thromb Haemost, 2013, vol. 11, pp. 679-85.
23. Weitz J.I., Lensing A.W., Prins M.H. et al. for the EINSTEIN CHOICE Investigators. Rivaroxaban or aspirin for extended treatment of venous thromboembolism. N. Engl. J. Med., 2017. doi: 10.1056/NEJMoa1700518.